Company Overview

Update
Status:
Acquired by Covidien
Founded:
2003
Headquarters:
Sunnyvale, CA
Funding:
$15M
Categories:
Health Care, Medical, Technology

GI Solutions focuses on the ongoing research and treatment of Barrett's esophagus for the treatment of patients diagnosed with the disease.

Description

Update

BÂRRX Medical, Inc. develops endoscopic treatment solutions for Barrett’s esophagus and other chronic gastroenterological diseases. Barrett’s is a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. The company’s HALOFLEX, HALO360 and HALO90 ablation systems are designed to provide a uniform and controlled ablation effect, in order to remove diseased tissue and allow re-growth of normal cells.

A multi-center randomized, sham-controlled study, published in the New England Journal of Medicine in 2009, studied HALO radiofrequency ablation applied in the highest risk Barrett’s population (those having dysplasia). The ablation group had a high rate of complete eradication of dysplasia and intestinal metaplasia and a significantly decreased rate of disease progression and cancer development, as compared to the control group. In another study... See More

Current Team (2)

Update

Board Members and Advisors (2)

Update

Funding Rounds (1) - $15M

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    540 Oakmead Parkway

    Sunnyvale, CA 94085

    USA